Botulinum a exotoxin for glabellar folds: A double-blind, placebo- controlled study with an electromyographic injection technique

Journal of the American Academy of Dermatology

Volumn 35, Issue 4, 1996, Pages 569-572

  Lowe, Nicholas J ^a,b,c   Maxwell, Anne ^b   Harper, Heather ^a,b  

^a Skin Res Foundation of California   (United States)

^b Cranley Clinic   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROMYOGRAM; FACE MUSCLE; HUMAN; HYPERKINESIA; INTRAMUSCULAR DRUG ADMINISTRATION; MOTOR DYSFUNCTION; PRIORITY JOURNAL;

EID: 0030481450     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90682-9     Document Type: Article

References (5)

1. Melling J, Hambleton P, Shone CC. Clostridium botulinum toxins: nature and preparation for clinical use. Eye 1988;2:16-23.
2. Jankovic J, Brin M. Therapeutic uses of botulinum toxin. N Engl J Med 1991;1186-94.
3. Carrathers J, Carruthers A. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 1992;18:17-21.
4. Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm. Can J Neurol Sci 1987;14:42-5.
5. Botulinum A exotoxin. Therapeutics and Technology Assessment Committee of the American Academy of Neurology. Neurology 1990;40:1332-3.